DSM – Repurchase of Shares (13-17 January 2020)
HEERLEN, Netherlands, Jan. 21, 2020 /PRNewswire/ — Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 213,886 of its own shares in the period from 13 January 2020 up to and including 17 January 2020 at an average price of EUR109.84. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was EUR23.5 million.
The total number of shares repurchased under this program to date is 8,430,721 shares for a total consideration of EUR920.6 million.
For more detailed information see ‘Daily transaction details Share Repurchase Program [https://www.dsm.com/corporate/investors/shares/share-buy-back-programs.html] announced 14 March 2019’.
DSM – Bright Science. Brighter Living.(TM)
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about EUR10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com [http://www.dsm.com/].
Or find us on: Facebook [https://www.facebook.com/DSMcompany] | Twitter [https://twitter.com/dsm] | LinkedIn [https://www.linkedin.com/company/3108] | YouTube [https://www.youtube.com/user/dsmcompany]
Logo – https://mma.prnewswire.com/media/657851/DSM_Logo.jpg [https://mma.prnewswire.com/media/657851/DSM_Logo.jpg]
CONTACT: DSM Media Relations, Lieke de Jong, tel. +31(0)45-5782420, e-mail email@example.com. DSM Investor Relations, Dave Huizing, tel. +31(0)45-5782864, e-mail firstname.lastname@example.org
Web site: http://www.dsm.com//